1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine

C134H187Cl2F3N30O15S7 — CID 159603933

IUPAC1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine
SMILESCCC(C)(C)c1ccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)cc1.CNC(=O)Nc1ccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)cc1.Cc1ccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)cc1C.Cc1cccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)c1.O=S(=O)(c1cc(Cl)cc(Cl)c1)N1CCN=C1N1CCN(C2CCC2)CC1.O=S(=O)(c1ccc2ccccc2c1)N1CCN=C1N1CCN(C2CCC2)CC1.O=S(=O)(c1cccc(C(F)(F)F)c1)N1CCN=C1N1CCN(C2CCC2)CC1
InChIInChI=1S/C22H34N4O2S.C21H26N4O2S.C19H28N6O3S.C19H28N4O2S.C18H23F3N4O2S.C18H26N4O2S.C17H22Cl2N4O2S/c1-4-22(2,3)18-8-10-20(11-9-18)29(27,28)26-13-12-23-21(26)25-16-14-24(15-17-25)19-6-5-7-19;26-28(27,20-9-8-17-4-1-2-5-18(17)16-20)25-11-10-22-21(25)24-14-12-23(13-15-24)19-6-3-7-19;1-20-18(26)22-15-5-7-17(8-6-15)29(27,28)25-10-9-21-19(25)24-13-11-23(12-14-24)16-3-2-4-16;1-15-6-7-18(14-16(15)2)26(24,25)23-9-8-20-19(23)22-12-10-21(11-13-22)17-4-3-5-17;19-18(20,21)14-3-1-6-16(13-14)28(26,27)25-8-7-22-17(25)24-11-9-23(10-12-24)15-4-2-5-15;1-15-4-2-7-17(14-15)25(23,24)22-9-8-19-18(22)21-12-10-20(11-13-21)16-5-3-6-16;18-13-10-14(19)12-16(11-13)26(24,25)23-5-4-20-17(23)22-8-6-21(7-9-22)15-2-1-3-15/h8-11,19H,4-7,12-17H2,1-3H3;1-2,4-5,8-9,16,19H,3,6-7,10-15H2;5-8,16H,2-4,9-14H2,1H3,(H2,20,22,26);6-7,14,17H,3-5,8-13H2,1-2H3;1,3,6,13,15H,2,4-5,7-12H2;2,4,7,14,16H,3,5-6,8-13H2,1H3;10-12,15H,1-9H2
InChIKeyMLVIVEXMSYTDOL-UHFFFAOYSA-N
MW2810.53 g/mol
LogP14.36
Rot. Bonds24

About 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine

1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine (PubChem CID 159603933) has the molecular formula C134H187Cl2F3N30O15S7 and a molecular weight of 2810.53 g/mol. Its IUPAC name is 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine.

Molecular Properties

Compound Name1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine
PubChem CID159603933
Molecular FormulaC134H187Cl2F3N30O15S7
Molecular Weight2810.53 g/mol
Exact Mass2807.22
IUPAC Name1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine
SMILESCCC(C)(C)c1ccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)cc1.CNC(=O)Nc1ccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)cc1.Cc1ccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)cc1C.Cc1cccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)c1.O=S(=O)(c1cc(Cl)cc(Cl)c1)N1CCN=C1N1CCN(C2CCC2)CC1.O=S(=O)(c1ccc2ccccc2c1)N1CCN=C1N1CCN(C2CCC2)CC1.O=S(=O)(c1cccc(C(F)(F)F)c1)N1CCN=C1N1CCN(C2CCC2)CC1
InChIInChI=1S/C22H34N4O2S.C21H26N4O2S.C19H28N6O3S.C19H28N4O2S.C18H23F3N4O2S.C18H26N4O2S.C17H22Cl2N4O2S/c1-4-22(2,3)18-8-10-20(11-9-18)29(27,28)26-13-12-23-21(26)25-16-14-24(15-17-25)19-6-5-7-19;26-28(27,20-9-8-17-4-1-2-5-18(17)16-20)25-11-10-22-21(25)24-14-12-23(13-15-24)19-6-3-7-19;1-20-18(26)22-15-5-7-17(8-6-15)29(27,28)25-10-9-21-19(25)24-13-11-23(12-14-24)16-3-2-4-16;1-15-6-7-18(14-16(15)2)26(24,25)23-9-8-20-19(23)22-12-10-21(11-13-22)17-4-3-5-17;19-18(20,21)14-3-1-6-16(13-14)28(26,27)25-8-7-22-17(25)24-11-9-23(10-12-24)15-4-2-5-15;1-15-4-2-7-17(14-15)25(23,24)22-9-8-19-18(22)21-12-10-20(11-13-21)16-5-3-6-16;18-13-10-14(19)12-16(11-13)26(24,25)23-5-4-20-17(23)22-8-6-21(7-9-22)15-2-1-3-15/h8-11,19H,4-7,12-17H2,1-3H3;1-2,4-5,8-9,16,19H,3,6-7,10-15H2;5-8,16H,2-4,9-14H2,1H3,(H2,20,22,26);6-7,14,17H,3-5,8-13H2,1-2H3;1,3,6,13,15H,2,4-5,7-12H2;2,4,7,14,16H,3,5-6,8-13H2,1H3;10-12,15H,1-9H2
InChIKeyMLVIVEXMSYTDOL-UHFFFAOYSA-N
XLogP14.36
TPSA434.67 Ų
H-Bond Donors2
H-Bond Acceptors36
Rotatable Bonds24
Heavy Atoms191
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002810.53
LogP ≤ 514.36
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1036

Analyze 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine?
The IUPAC name of 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine (CID 159603933) is 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine.
What is the SMILES notation for 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine?
The canonical SMILES for 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine is CCC(C)(C)c1ccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)cc1.CNC(=O)Nc1ccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)cc1.Cc1ccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)cc1C.Cc1cccc(S(=O)(=O)N2CCN=C2N2CCN(C3CCC3)CC2)c1.O=S(=O)(c1cc(Cl)cc(Cl)c1)N1CCN=C1N1CCN(C2CCC2)CC1.O=S(=O)(c1ccc2ccccc2c1)N1CCN=C1N1CCN(C2CCC2)CC1.O=S(=O)(c1cccc(C(F)(F)F)c1)N1CCN=C1N1CCN(C2CCC2)CC1.
What is the InChIKey of 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine?
The InChIKey is MLVIVEXMSYTDOL-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H34N4O2S.C21H26N4O2S.C19H28N6O3S.C19H28N4O2S.C18H23F3N4O2S.C18H26N4O2S.C17H22Cl2N4O2S/c1-4-22(2,3)18-8-10-20(11-9-18)29(27,28)26-13-12-23-21(26)25-16-14-24(15-17-25)19-6-5-7-19;26-28(27,20-9-8-17-4-1-2-5-18(17)16-20)25-11-10-22-21(25)24-14-12-23(13-15-24)19-6-3-7-19;1-20-18(26)22-15-5-7-17(8-6-15)29(27,28)25-10-9-21-19(25)24-13-11-23(12-14-24)16-3-2-4-16;1-15-6-7-18(14-16(15)2)26(24,25)23-9-8-20-19(23)22-12-10-21(11-13-22)17-4-3-5-17;19-18(20,21)14-3-1-6-16(13-14)28(26,27)25-8-7-22-17(25)24-11-9-23(10-12-24)15-4-2-5-15;1-15-4-2-7-17(14-15)25(23,24)22-9-8-19-18(22)21-12-10-20(11-13-21)16-5-3-6-16;18-13-10-14(19)12-16(11-13)26(24,25)23-5-4-20-17(23)22-8-6-21(7-9-22)15-2-1-3-15/h8-11,19H,4-7,12-17H2,1-3H3;1-2,4-5,8-9,16,19H,3,6-7,10-15H2;5-8,16H,2-4,9-14H2,1H3,(H2,20,22,26);6-7,14,17H,3-5,8-13H2,1-2H3;1,3,6,13,15H,2,4-5,7-12H2;2,4,7,14,16H,3,5-6,8-13H2,1H3;10-12,15H,1-9H2.
What are the key properties of 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine?
1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine has a molecular weight of 2810.53 g/mol, XLogP of 14.36, 24 rotatable bonds, 2 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 1-cyclobutyl-4-[1-(3,5-dichlorophenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3,4-dimethylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-[4-(2-methylbutan-2-yl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-[1-(3-methylphenyl)sulfonyl-4,5-dihydroimidazol-2-yl]piperazine;1-cyclobutyl-4-(1-naphthalen-2-ylsulfonyl-4,5-dihydroimidazol-2-yl)piperazine;1-[4-[[2-(4-cyclobutylpiperazin-1-yl)-4,5-dihydroimidazol-1-yl]sulfonyl]phenyl]-3-methylurea;1-cyclobutyl-4-[1-[3-(trifluoromethyl)phenyl]sulfonyl-4,5-dihydroimidazol-2-yl]piperazine is sourced from PubChem (CID 159603933), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).